Cluster-Based CKD Management
Cross-source consensus on Cluster-Based CKD Management from 1 sources and 4 claims.
1 sources · 4 claims
Uses
Benefits
Evidence quality
Highlighted claims
- Longitudinal monitoring of SBP, fasting glucose, and LDL cholesterol may help stratify risk among patients with advanced CKD. — Trajectories of metabolic risk clusters and adverse outcomes in patients with chronic kidney disease: a prospective cohort study in Taiwan
- The study supports routine repeated assessment of metabolic risk profiles in CKD care. — Trajectories of metabolic risk clusters and adverse outcomes in patients with chronic kidney disease: a prospective cohort study in Taiwan
- The trajectories should be interpreted as real-world metabolic control patterns shaped by disease biology and treatment effects. — Trajectories of metabolic risk clusters and adverse outcomes in patients with chronic kidney disease: a prospective cohort study in Taiwan
- The findings support managing concurrent metabolic abnormalities as clusters rather than relying only on single-factor strategies. — Trajectories of metabolic risk clusters and adverse outcomes in patients with chronic kidney disease: a prospective cohort study in Taiwan